Navigation Links
Decision Resources' White Paper Discusses Increasing Reality of Biosimilars and their Impact on Biologics Market

WALTHAM, Mass., Nov. 5 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, today announced that it is making available its white paper, From Biologics to Biosimilars - How Will the Market Evolve? Addressing timing, hurdles that must be overcome and ultimately who has the most to lose, this paper guides readers through the biologics/biosimilars conundrum with the aid of data and analysis from Pharmaview.

Topics covered in the white paper include:

-- Patent expiries and anticipated biosimilar entry dates for key biologic


-- Companies at risk from biosimilars

-- Who the key competitors will be in the biosimilars market

If you would like to download a copy of the white paper, please visit:

About Pharmaview

Pharmaview provides continually updated analysis on over 1,500 marketed and pipeline products from over 120 companies, covering 136 product classes and 14 therapy areas - complete with seven-year product-level forecasts for over 1,000 products.

About Decision Resources

Decision Resources ( is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Heather Hilty Elizabeth Marshall

Decision Resources Decision Resources, Inc.

781-296-2536 781-296-2563

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Schering-Plough to Appeal Jury Decision in Missouri Reimbursement Case
2. APTA Podcast Helps Voters Make Informed Decisions on Presidential Candidates Health Care Plans
3. Videoconferencing more confusing for decision-makers than face-to-face meetings
4. Elderly fare better when included in decisions on treatment trade-offs
5. Agency Takes Adverse Decision to Biopures Product Registration in South Africa
6. Top 10 Things Pharma Should Know About India - Free Paper From Decision Resources
7. DecisionView Unveils the Next Generation of Clinical Trial Software: StudyOptimizer 4.0
8. Decision Intelligence Delivers Marketing Contact Optimization Solutions
9. Hard Decisions for the Littlest Lives
10. AxoGen Awarded Accreditation from American Association of Tissue Banks : Decision Affirms AxoGen's Commitment to Safety and Ethicality in the Development and Distribution of AVANCE Nerve Graft for Treatment of Peripheral Nerve Injuries
11. Fear of Losing Key Emotion in Economic Decisions
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... An inventor, ... to dispense prescription medications at home, so he invented the patent-pending ELECTRONIC M.D. ... dispense prescription medications. In doing so, it could help to prevent potential overdose ...
(Date:11/27/2015)... ... ... No.1 Herpes-only dating community in the world, revealed that over 50% of its members are ... people under the age of 50 – or 67% of the population - are infected ... HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping ... platform for mental health and wellness consultation, has collaborated with a leading web-based ... the knowledge gap experienced by parents and bring advice from parenting experts within ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... contact center software Q-Suite, announces the incorporation of Asterisk 11 LTS (Long Term ... fully supported Asterisk 11 LTS brings Q-Suite 5.10 up-to-date with a version of ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug ... need to integrate dose form selection in early phase drug development. The first ... supporting and bringing together the UK’s emerging life sciences companies, corporate partners, and ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... 2015 ... "2016 Global Tumor Marker Testing Market: ... Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, ... their offering. --> ) ... "2016 Global Tumor Marker Testing Market: Supplier ...
(Date:11/26/2015)... 2015 --> ... combineert immunotherapie met Bremachlorin-photodynamische therapie voor de ... ) --> ... ) Uit een ... (LUMC) blijkt dat ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
Breaking Medicine Technology: